ClinicalTrials.gg
Drug

Reteplase clinical trials

Also written CUSA-081.

studies test it
7
open now
1
in phase 3
5
first study started
2003

How each study uses reteplase is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the reteplase studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Oct 1996 · Retavase · BLA 103786 (FDA, Purple Book)
European Union
29 Aug 1996 · Rapilysin · EMEA/H/C/000105 (EMA; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Reteplase
3
Reteplase 10 Units (U) plus a second dose of reteplase 10 U
2

Brand

Retavase
1

Development codes

CUSA-081
2

Studies by the year they started

7 studies that test it; most in 2022 (2)

Studies that test reteplase, by start year
YearStudies
20031
20201
20211
20222
20231
20261

By phase

A phase 1/2 study counts in both.

Phase 2
1
Phase 3
5
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 3 · Other 4

Chiesi Farmaceutici S.p.A. (2) · Angde Biotech Pharmaceutical Co., Ltd. (1) · The University of Texas Health Science Center, Houston (1) · Yongjun Wang (1) · Ge Junbo (1) · Zeenat Qureshi Stroke Institute (1)

Often tested with

Tested in the same studies.

Tenecteplase (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses reteplase is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 7

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call reteplase · ClinicalTrials.gg INT003791

  • MeSH (NLM) C087896reteplaseConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) DQA630RIE9RETEPLASEConfirmed FDA, NLM, Wikidata
  • RxNorm 76895Confirmed FDA, Wikidata
  • Wikidata Q3933703reteplaseConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C90972ReteplaseOne source FDA
  • DrugBank DB00015One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.